CM Management »

Pieris Pharmaceuticals shares owned by CM Management

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by CM Management from 13F filings

Historical chart of CM Management investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by CM Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by CM Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $373k 23k 16.58

More positions owned by CM Management

Arko Corp (ARKO)
Ali (ALCO)
Taseko Cad (TGB)
Radiant Logistics (RLGT)
Amicus Therapeutics (FOLD)
Rigel Pharmaceuticals (RIGL)
Newmark Group Com - Class A (NMRK)
Royalty Pharma Com - Class A (RPRX)
Talos Energy (TALO)
Preformed Line Products Company (PLPC)
Clearpoint Neuro (CLPT)
Kyndryl Holdings Ord Wi (KD)
Pagerduty (PD)
inTEST Corporation (INTT)
Bgc Group Com - Class A (BGC)

View all positions for CM Management

Top funds holding Pieris Pharmaceuticals

BVF
BML Capital Management
Lynx1 Capital Management
Renaissance Technologies
CM Management
Frazier Life Sciences Management
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Group
Acadian Asset Management
Citigroup
Tower Research Capital
Group One Trading

View all funds holding Pieris Pharmaceuticals